Cetera Investment Advisers
INDV icon

Cetera Investment Advisers’s Indivior Pharmaceuticals INDV Stock Holding History

Cetera Investment Advisers’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$958K Buy
31,424
+383
+1% +$12.6K ﹤0.01% 2942
2025
Q4 		$1.11M Sell
31,041
-19,280
-38% -$589K ﹤0.01% 2731
2025
Q3 		$1.21M Buy
+50,321
New +$1.05M ﹤0.01% 2611

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cetera Investment Advisers's INDV Position: Q1 2026 in Review

Cetera Investment Advisers increased its Indivior Pharmaceuticals (INDV) stake by 1.2% in Q1 2026, buying an estimated $12.6K and bringing the position to 31,424 shares worth $958K. The position accounts for ﹤0.01% of the portfolio, ranked #2942.

Cetera Investment Advisers first reported a position in INDV in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.21M in Q3 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Cetera Investment Advisers held 31,424 shares of Indivior Pharmaceuticals worth $958K as of Q1 2026.
  • Cetera Investment Advisers bought 383 Indivior Pharmaceuticals shares in Q1 2026, an estimated $12.6K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #2942 holding.
  • Cetera Investment Advisers first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Cetera Investment Advisers's Indivior Pharmaceuticals position peaked at $1.21M in Q3 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.